High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy

Gerome V. Escota, Kristin Mondy, Tim Bush, Lois Conley, John T. Brooks, Nur Önen, Pragna Patel, Erna Milunka Kojic, Keith Henry, John Hammer, K. C. Wood, Kenneth A. Lichtenstein, Edgar T. Overton

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

HIV-infected persons are living longer on combination antiretroviral therapy (cART) but experiencing more comorbidities including low bone mineral density (BMD). Using data from the Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN Study), we determined the prevalence of low BMD (T-score below one standard deviation of the reference mean) and compared it with matched controls from the National Health and Nutrition Examination Survey (NHANES). We also assessed 4-year longitudinal BMD changes among participants virologically suppressed on cART. Of 653 participants included in this analysis (77% male, 29% black, median age 41 years, median CD4+ cell count 464 cells/mm3, 89% with HIV RNA

Original languageEnglish (US)
Pages (from-to)59-67
Number of pages9
JournalAIDS Research and Human Retroviruses
Volume32
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Bone Density
HIV
Bone and Bones
Nutrition Surveys
CD4 Lymphocyte Count
Natural History
Comorbidity
Acquired Immunodeficiency Syndrome
Therapeutics
Cross-Sectional Studies
RNA

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy. / Escota, Gerome V.; Mondy, Kristin; Bush, Tim; Conley, Lois; Brooks, John T.; Önen, Nur; Patel, Pragna; Kojic, Erna Milunka; Henry, Keith; Hammer, John; Wood, K. C.; Lichtenstein, Kenneth A.; Overton, Edgar T.

In: AIDS Research and Human Retroviruses, Vol. 32, No. 1, 01.01.2016, p. 59-67.

Research output: Contribution to journalArticle

Escota, GV, Mondy, K, Bush, T, Conley, L, Brooks, JT, Önen, N, Patel, P, Kojic, EM, Henry, K, Hammer, J, Wood, KC, Lichtenstein, KA & Overton, ET 2016, 'High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy', AIDS Research and Human Retroviruses, vol. 32, no. 1, pp. 59-67. https://doi.org/10.1089/aid.2015.0158
Escota, Gerome V. ; Mondy, Kristin ; Bush, Tim ; Conley, Lois ; Brooks, John T. ; Önen, Nur ; Patel, Pragna ; Kojic, Erna Milunka ; Henry, Keith ; Hammer, John ; Wood, K. C. ; Lichtenstein, Kenneth A. ; Overton, Edgar T. / High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy. In: AIDS Research and Human Retroviruses. 2016 ; Vol. 32, No. 1. pp. 59-67.
@article{56035a0e250e404ca6dca16803c85690,
title = "High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy",
abstract = "HIV-infected persons are living longer on combination antiretroviral therapy (cART) but experiencing more comorbidities including low bone mineral density (BMD). Using data from the Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN Study), we determined the prevalence of low BMD (T-score below one standard deviation of the reference mean) and compared it with matched controls from the National Health and Nutrition Examination Survey (NHANES). We also assessed 4-year longitudinal BMD changes among participants virologically suppressed on cART. Of 653 participants included in this analysis (77{\%} male, 29{\%} black, median age 41 years, median CD4+ cell count 464 cells/mm3, 89{\%} with HIV RNA",
author = "Escota, {Gerome V.} and Kristin Mondy and Tim Bush and Lois Conley and Brooks, {John T.} and Nur {\"O}nen and Pragna Patel and Kojic, {Erna Milunka} and Keith Henry and John Hammer and Wood, {K. C.} and Lichtenstein, {Kenneth A.} and Overton, {Edgar T.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1089/aid.2015.0158",
language = "English (US)",
volume = "32",
pages = "59--67",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy

AU - Escota, Gerome V.

AU - Mondy, Kristin

AU - Bush, Tim

AU - Conley, Lois

AU - Brooks, John T.

AU - Önen, Nur

AU - Patel, Pragna

AU - Kojic, Erna Milunka

AU - Henry, Keith

AU - Hammer, John

AU - Wood, K. C.

AU - Lichtenstein, Kenneth A.

AU - Overton, Edgar T.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - HIV-infected persons are living longer on combination antiretroviral therapy (cART) but experiencing more comorbidities including low bone mineral density (BMD). Using data from the Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN Study), we determined the prevalence of low BMD (T-score below one standard deviation of the reference mean) and compared it with matched controls from the National Health and Nutrition Examination Survey (NHANES). We also assessed 4-year longitudinal BMD changes among participants virologically suppressed on cART. Of 653 participants included in this analysis (77% male, 29% black, median age 41 years, median CD4+ cell count 464 cells/mm3, 89% with HIV RNA

AB - HIV-infected persons are living longer on combination antiretroviral therapy (cART) but experiencing more comorbidities including low bone mineral density (BMD). Using data from the Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN Study), we determined the prevalence of low BMD (T-score below one standard deviation of the reference mean) and compared it with matched controls from the National Health and Nutrition Examination Survey (NHANES). We also assessed 4-year longitudinal BMD changes among participants virologically suppressed on cART. Of 653 participants included in this analysis (77% male, 29% black, median age 41 years, median CD4+ cell count 464 cells/mm3, 89% with HIV RNA

UR - http://www.scopus.com/inward/record.url?scp=84954165767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954165767&partnerID=8YFLogxK

U2 - 10.1089/aid.2015.0158

DO - 10.1089/aid.2015.0158

M3 - Article

C2 - 26366785

AN - SCOPUS:84954165767

VL - 32

SP - 59

EP - 67

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 1

ER -